Through spatial and molecular profiling, they found that CD8+ cytotoxic T cells in tumor-rich regions expressed effector molecules such as PRF1, GZMK, and TNF, indicating preserved cytotoxic function. The gene discussed is GZMK; the disease is neoplasm.